# SEEG-Guided DBS for Schizophrenia

> **NCT07671261** · NA · RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 46 (estimated)

## Conditions studied

- Schizophrenia Disorders
- Schizo Affective Disorder

## Interventions

- **PROCEDURE:** SEEG implantation
- **DEVICE:** Deep brain stimulation

## Key facts

- **NCT ID:** NCT07671261
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-17
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2026-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07671261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07671261, "SEEG-Guided DBS for Schizophrenia". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07671261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*